Network pharmacology: New opportunity for the modernization of traditional Chinese medicine

Yaoxue Xuebao

Volumn 47, Issue 6, 2012, Pages 696-703

  Liu, Zhi Hua ^a   Sun, Xiao Bo ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

Effective substance base; Herbal formula compatibility; Holistic view; Modernization of traditional Chinese medicine; Network pharmacology; Syndrome

Indexed keywords

CHINESE DRUG;

CHINESE MEDICINE; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG QUALITY; DRUG RESEARCH; DRUG TARGETING; INFORMATION SYSTEM; METHODOLOGY; MODERN TIMES; NETWORK PHARMACOLOGY; PHENOTYPE; REPRODUCIBILITY; REVIEW; SYNDROME; SYSTEM ANALYSIS;

DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEURAL NETWORKS (COMPUTER); PHARMACOLOGY;

EID: 84865321882     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Qiu J. China plans to modernize traditional medicine [J]. Nature, 2007, 446: 590-591.
2. Qiu J. Traditional medicine: a culture in the balance [J]. Nature, 2007, 448: 126-128.
3. Qiu J. Back to the future for Chinese herbal medicines [J]. Nat Rev Drug Discov, 2007, 6: 506-507.
4. Yan D, Xiao XH. Investigation on pattern and methods of quality control for Chinese materia medica based on Dao-di herbs and bioassay - bioassay for Coptis chinensis [J]. Acta Pharm Sin, 2011, 46: 568-572.
5. Hopkins AL. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol, 2008, 4: 682-690.
6. Hopkins AL. Network pharmacology [J]. Nat Biotechnol, 2007, 25: 1110-1111.
7. Pan JH. New paradigm for drug discovery based on network pharmacology [J]. Chin J New Drugs Clin Rem, 2009, 28: 721-726.
8. Goh KI, Cusick ME, Valle D, et al. The human disease network [J]. Proc Natl Acad Sci USA, 2007, 104: 8685-8690.
9. Kaufmann SHE. Paul Ehrlich: founder of chemotherapy [J]. Nat Rev Drug Discov, 2008, 7: 373.
10. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? [J]. Nat Rev Drug Discov, 2004, 3: 711-715.
11. Huang M, Zhu C, Liang QL, et al. Effect of Tangshen Formula on phospholipids metabolism in diabetic nephropathy patients [J]. Acta Pharm Sin, 2011, 46: 780-786.
12. Xiao PG. The progress of traditional Chinese medicine in the twenty-first century [J]. Res Inf Tradit Chin Med 2005, 7: 6-7.
13. Luo GA, Liang QL, Zhang RL, et al. Study of chemical matteromics and prescription of traditional Chinese medicine - and an analysis of material foundation of compound prescription Qingkailing [J]. World Sci Technol Mod Tradit Chin Med Mater Med, 2006, 8: 6-15.
14. Wang Y, Wang G, Xiao B, et al. Constructing method of the functional network of activating blood and dissolving stasis [J]. World Sci Technol Mod Tradit Chin Med Mater Med, 2010, 12: 764-767.
15. Wu X, Jiang R, Zhang MQ, et al. Network-based global inference of human disease genes [J]. Mol Syst Biol, 2008, 4: 1-11.
16. Liu AL, Du GH. Network pharmacology: new guidelines for drug discovery [J]. Acta Pharm Sin, 2010, 45: 1472-1477.
17. Wang J, Li XJ. Drug targets discovery based on dynamic signal transduction networks [J]. Acta Pharm Sin, 2010, 45: 1-8.
18. Xu Y, Chen CC, Yang L, et al. Evaluation on hepatotoxicity caused by Dioscorea bulbifera based on analysis of bile acids [J]. Acta Pharm Sin, 2011, 46: 39-44.
19. Li S. Network target: a starting point for traditional Chinese medicine network pharmacology [J]. China J Chin Mater Med, 2011, 36: 2017-2020.
20. Seebacher J, Gavin AC. Snapshot: protein-protein interaction networks [J]. Cell, 2011, 144: 1000, 1000.e1.
21. Gao ZY, Zhang JC, Xu H, et al. Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks [J]. J Chin Integ Med, 2010, 8: 238-242.
22. Cui JK, Na K. A overview on the therapeutic role of traditional Chinese medicine in the coronary heart disease [J]. J Emerg Syndromes Tradit Chin Med, 2010, 19: 649-650.
23. Kang GL, Li S, Zhang JF. Entropy-based model for interpreting life systems in traditional Chinese medicine [J]. Evid Based Complement Alternat Med, 2008, 5: 273-279.
24. Wu M, Ma CH, Wu Y, et al. Simultaneous LC analysis of five bioactive alkaloids in an anti-angiogenesis herbal formula, Qing-Luo-Yin [J]. Chromatographia, 2008, 68: 579-585.
25. Li S. Network systems underlying traditional Chinese medicine syndrome and herb formula [J]. Curr Bioinform, 2009, 4: 188-196.
26. Li S, Zhang B, Zhang NB. Network target for screening synergistic drug combinations with application to traditional Chinese medicine [J]. BMC Syst Biol, 2011, 5: S10.
27. Chen KX, Jiang HL, Luo XM, et al. Drug discovery in post-genome era: trend and practice [J]. Chin J Nat Med, 2004, 2: 257-260.
28. Li S, Zhang B, Jiang D, et al. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae [J]. BMC Bioinformatics, 2010, 11: S6.
29. Zhang J, Ma T, Li YD, et al. dbNEI2.0: building multilayer network for drug-NEI-disease [J]. Bioinformatics, 2008, 24: 2409-2411.
30. Zhuang YL, Li S, Li YD. dbNEI: a specific database for neuro-endocrine-immune interactions [J]. Neuro Endocrinol Lett, 2006, 27: 53-59.
31. Li S, Zhang Z, Wu L, et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network [J]. IET Syst Biol, 2007, 1: 51-60.
32. Wang Y, Zhang YL, Shi XY, et al. Construction and application of TCM function networks [J]. World Sci Technol Mod Tradit Chin Med Mater Med, 2008, 10: 105-108.
33. Xiong JH, Liu J, Rayner S, et al. Pre-clinical drug prioritization via prognosis-guided genetic interaction networks [J]. PLoS One, 2010, 5:e13937.
34. Zhang P, Li J, Wang Y, et al. Bayesian belief network and its application in predicting the five flavors of Chinese medicinal components [J]. World Sci Technol Mod Tradit Chin Med Mater Med, 2008, 10: 114-117.
35. Liu H, Tu Q, Zhou XZ, et al. The parallel algorithm of the traditional Chinese medicine herb combination network construction [J]. China Dig Med, 2010, 5: 39-41.
36. Xiong JH, Rayner S, Luo KY, et al. Genome wide prediction of protein function via a generic knowledge discovery approach based on evidence integration [J]. BMC Bioinformatics, 2006, 7: 268.
37. Zhu W, Qiu XH, Xu XJ, et al. Computational network pharmacological research of Chinese medicinal plants for chronic disease [J]. Sci Sin B, 2010, 40: 1085-1090.
38. Gu JY, Yuan G, Zhu YH, et al. Computational pharmacological studies on cardiovascular disease by Qishen Yiqi Diwan [J]. Sci Sin B, 2009, 39: 1415-1423.
39. Zheng QS, Xu XJ, Liu XX, et al. Computational pharmacology of Jingzhi Tougu Xiaotong granule in preventing and treating Osteoarthritis [J]. Acta Phys Chim Sin, 2010, 26: 775-783.
40. Zhao S, Li S. Network-based relating pharmacological and genomic spaces for drug target identification [J]. PLoS One, 2010, 5: e11764.
41. Zhou MM, Liu P, Jia W, et al. Evaluation of therapeutic effects of TCM based on metabolic variation [J]. World Sci Technol Mod Tradit Chin Med Mater Med, 2006, 8: 113-119.
42. Liu ZH, Chen SL. ER regulates an evolutionarily conserved apoptosis pathway [J]. Biochem Biophys Res Commun, 2010, 400: 34-38.
43. Wang Y, Gao XM, Zhang BL, et al. Building methodology for discovering and developing Chinese medicine based on network biology [J]. China J Chin Mater Med, 2011, 36: 228-231.